📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Oral disease in relation to future risk of dementia and cognitive decline: prospective cohort study based on the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation (ADVANCE) trial. (2013)

First Author: Batty GD

Attributed to: Centre for Cognitive Ageing & Cognitive Epidemiology funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.eurpsy.2011.07.005

PubMed Identifier: 21964484

Publication URI: http://europepmc.org/abstract/MED/21964484

Type: Journal Article/Review

Volume: 28

Parent Publication: European psychiatry : the journal of the Association of European Psychiatrists

Issue: 1

ISSN: 0924-9338